Mohammed Suleiman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohammed Suleiman has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Andrés Pérez-López
Division of Microbiology, Department of Pathology, Sidra Medicine, Doha, Qatar
17 shared publications Andrés Pérez-López
Sidra Medicine , Doha, Qatar
10 shared publications- Patrick Tang
Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, British Columbia
9 shared publications - Mohammad Rubayet Hasan
Affiliations Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada, Research Institute of St. Joe’s Hamilton, Hamilton, Canada, Hamilton Regional Laboratory Medicine Program, Hamilton, Canada
6 shared publications Patrick Tang
6 shared publicationsNazik Elamin
Sidra Medicine, PO Box 26999, Doha, Qatar
4 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by Elsevier in The Lancet Regional Health - Eastern Mediterranean
- Vol. 2
Relative severity of severe acute respiratory syndrome coronavirus 2, influenza, and respiratory syncytial virus among pediatric emergency department attendees in Qatar: a retrospective cohort study
- 13 October 2026
- Published by Elsevier in The Lancet Regional Health - Eastern Mediterranean
- Vol. 2
Open AccessRelative severity of severe acute respiratory syndrome coronavirus 2, influenza, and respiratory syncytial virus among pediatric emergency department attendees in Qatar: a retrospective cohort study
- 10 October 2026
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 166 (4)
Correspondence: from incident reporting to predictive safety surveillance: the role of laboratory quality indicators
- 10 October 2026
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 166 (4)
Correspondence: from incident reporting to predictive safety surveillance: the role of laboratory quality indicators
- 30 September 2026
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- p. 1-13
Standardization and evaluation of artificial intelligence-driven Fourier-transform infrared bio-typing for the discrimination of Escherichia coli and Shigella spp. on genus, species and serogroup level
- 30 September 2026
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- p. 1-13
Standardization and evaluation of artificial intelligence-driven Fourier-transform infrared bio-typing for the discrimination of Escherichia coli and Shigella spp. on genus, species and serogroup level
- Open Access
- 15 July 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1847592
Fourier-transform infrared spectroscopy with machine learning for rapid O-serogrouping and typhi differentiation of clinical Salmonella isolates
Salmonella enterica remains a leading cause of gastrointestinal infections worldwide, requiring rapid and accurate typing for effective outbreak management and clinical treatment. Traditional serological methods, such as the Kauffmann–White scheme, are labor-intensive, time-consuming, and require specialized expertise. This study evaluated the IR Biotyper (IRBT) system, which combines Fourier-transform infrared (FTIR) spectroscopy with machine learning algorithms, for rapid classification of clinical Salmonella isolates at the O-serogroup level and for differentiating S . Typhi from non-typhoidal Salmonella (NTS) in a routine pediatric microbiology setting in the Middle East. A total of 164 clinical isolates from blood and stool cultures were analyzed, generating 1,925 spectra for serogroup classification and 790 spectra for the Typhi vs. NTS classifier. Using the Wellcolex™ Color Salmonella kit as a reference, the IRBT O-group classifier achieved an overall accuracy of 98.2%, correctly identifying 161 of 164 isolates. The system reached 100% accuracy for Groups A ( n = 4, 95% CI: 39.8%–100%), A+E/G ( n = 5, 95% CI: 47.8%–100%), B ( n = 40, 95% CI: 91.2%–100%), C+D ( n = 13, 95% CI: 75.3%–100%), D ( n = 49, 95% CI: 92.7%–100%), and isolates expressing the Vi antigen ( n = 2, 95% CI: 15.8%–100%), while Group E/G showed lower accuracy at 89.5%. The Typhi vs. NTS classifier achieved 100% accuracy in both internal validation ( n = 34, 95% CI: 89.8%–100%) and independent testing ( n = 31, 95% CI: 88.8%–100%), demonstrating complete concordance with the Vi antiserum assay. These results indicate that FTIR spectroscopy offers a rapid, reliable, and user-friendly alternative to conventional serotyping, reducing turnaround time to under 2 h. Integration of this technology into clinical microbiology workflows provides a robust tool for real-time pathogen monitoring and enhanced public health response.
- 15 July 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1847592
Open AccessFourier-transform infrared spectroscopy with machine learning for rapid O-serogrouping and typhi differentiation of clinical Salmonella isolates
Salmonella enterica remains a leading cause of gastrointestinal infections worldwide, requiring rapid and accurate typing for effective outbreak management and clinical treatment. Traditional serological methods, such as the Kauffmann–White scheme, are labor-intensive, time-consuming, and require specialized expertise. This study evaluated the IR Biotyper (IRBT) system, which combines Fourier-transform infrared (FTIR) spectroscopy with machine learning algorithms, for rapid classification of clinical Salmonella isolates at the O-serogroup level and for differentiating S . Typhi from non-typhoidal Salmonella (NTS) in a routine pediatric microbiology setting in the Middle East. A total of 164 clinical isolates from blood and stool cultures were analyzed, generating 1,925 spectra for serogroup classification and 790 spectra for the Typhi vs. NTS classifier. Using the Wellcolex™ Color Salmonella kit as a reference, the IRBT O-group classifier achieved an overall accuracy of 98.2%, correctly identifying 161 of 164 isolates. The system reached 100% accuracy for Groups A ( n = 4, 95% CI: 39.8%–100%), A+E/G ( n = 5, 95% CI: 47.8%–100%), B ( n = 40, 95% CI: 91.2%–100%), C+D ( n = 13, 95% CI: 75.3%–100%), D ( n = 49, 95% CI: 92.7%–100%), and isolates expressing the Vi antigen ( n = 2, 95% CI: 15.8%–100%), while Group E/G showed lower accuracy at 89.5%. The Typhi vs. NTS classifier achieved 100% accuracy in both internal validation ( n = 34, 95% CI: 89.8%–100%) and independent testing ( n = 31, 95% CI: 88.8%–100%), demonstrating complete concordance with the Vi antiserum assay. These results indicate that FTIR spectroscopy offers a rapid, reliable, and user-friendly alternative to conventional serotyping, reducing turnaround time to under 2 h. Integration of this technology into clinical microbiology workflows provides a robust tool for real-time pathogen monitoring and enhanced public health response.
- Open Access
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0005526
Diagnostic performance of the QIAstat-Dx gastrointestinal panel compared with conventional methods in pediatric gastroenteritis
Pediatric gastroenteritis remains a significant public health issue, underscoring the need for better laboratory diagnostic methods. Traditional diagnostic techniques, such as stool culture and ova and parasite (O&P) examination, are limited by long turnaround times and low detection rates. This study assessed the diagnostic capabilities of the QIAstat-Dx Gastrointestinal Panel (QGP), a multiplex PCR test, against conventional stool culture and O&P examination in 4,801 clinical stool samples from pediatric patients at Sidra Medicine. The study involved stool specimens collected from patients aged ≤18 years who were being tested for gastroenteritis using one or more of the following methods: QGP, stool culture, and O&P examination. QGP demonstrated a higher pathogen detection rate (42.3%; 2,033/4,801) than stool culture (12.6%; 255/2,018) and O&P examination (6.3%; 63/986). A total of 2,814 pathogens were identified in the 2,033 QGP-positive samples, with EPEC being the most prevalent pathogen found in 631 samples (13.1%). QGP showed high concordance with conventional methods, with >98% negative percent agreement (NPA) for all targets and 100% positive percent agreement (PPA) for all targets, except Salmonella spp. (84.4% PPA). The lower PPA for Salmonella spp. was attributed to isolates detected only by culture after enrichment with Selenite F broth. QGP had a shorter median turnaround time from sample collection to final results (2.8 h) than stool culture (67.6 h) and O&P examination (38.8 h). QGP is a valuable diagnostic tool due to improved detection rate, ability to detect co-infection, and quicker turnaround time, providing a more efficient and comprehensive approach in pediatric gastroenteritis diagnosis. IMPORTANCE: This study highlights the benefits of using multiplex PCR panels, such as the QIAstat-Dx Gastrointestinal Panel (QGP), which provides results for 23 pathogens simultaneously within 80 min. This extensive retrospective study evaluated the performance of QGP in 4,801 stool samples collected in a pediatric tertiary care center in Qatar. The QGP showed superior diagnostic performance compared with traditional methods, including enhanced pathogen detection and faster results, helping clinicians optimize the treatment of children with gastroenteritis.
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0005526
Open AccessDiagnostic performance of the QIAstat-Dx gastrointestinal panel compared with conventional methods in pediatric gastroenteritis
Pediatric gastroenteritis remains a significant public health issue, underscoring the need for better laboratory diagnostic methods. Traditional diagnostic techniques, such as stool culture and ova and parasite (O&P) examination, are limited by long turnaround times and low detection rates. This study assessed the diagnostic capabilities of the QIAstat-Dx Gastrointestinal Panel (QGP), a multiplex PCR test, against conventional stool culture and O&P examination in 4,801 clinical stool samples from pediatric patients at Sidra Medicine. The study involved stool specimens collected from patients aged ≤18 years who were being tested for gastroenteritis using one or more of the following methods: QGP, stool culture, and O&P examination. QGP demonstrated a higher pathogen detection rate (42.3%; 2,033/4,801) than stool culture (12.6%; 255/2,018) and O&P examination (6.3%; 63/986). A total of 2,814 pathogens were identified in the 2,033 QGP-positive samples, with EPEC being the most prevalent pathogen found in 631 samples (13.1%). QGP showed high concordance with conventional methods, with >98% negative percent agreement (NPA) for all targets and 100% positive percent agreement (PPA) for all targets, except Salmonella spp. (84.4% PPA). The lower PPA for Salmonella spp. was attributed to isolates detected only by culture after enrichment with Selenite F broth. QGP had a shorter median turnaround time from sample collection to final results (2.8 h) than stool culture (67.6 h) and O&P examination (38.8 h). QGP is a valuable diagnostic tool due to improved detection rate, ability to detect co-infection, and quicker turnaround time, providing a more efficient and comprehensive approach in pediatric gastroenteritis diagnosis. IMPORTANCE: This study highlights the benefits of using multiplex PCR panels, such as the QIAstat-Dx Gastrointestinal Panel (QGP), which provides results for 23 pathogens simultaneously within 80 min. This extensive retrospective study evaluated the performance of QGP in 4,801 stool samples collected in a pediatric tertiary care center in Qatar. The QGP showed superior diagnostic performance compared with traditional methods, including enhanced pathogen detection and faster results, helping clinicians optimize the treatment of children with gastroenteritis.
- Open Access
- 18 June 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (8) , e0089026
Evaluation of BD Phoenix CPO Detect and NG-Test CARBA 5 for the detection and classification of carbapenemase-producing Enterobacterales using whole-genome sequencing as the reference standard
Rapid detection and accurate classification of carbapenemase-producing Enterobacterales (CPE) are essential for antimicrobial stewardship and infection prevention. We evaluated the performance of the BD Phoenix CPO Detect (BD-CPO) assay and the NG-Test CARBA 5 (NG-C5) using whole-genome sequencing (WGS) as the reference standard in a tertiary pediatric center. A total of 161 non-duplicate WGS-confirmed CPE isolates recovered from clinical and screening specimens were included. NG-C5 demonstrated a sensitivity of 99.4%, correctly identifying and classifying carbapenemase genes in 160 of 161 isolates, including those harboring dual carbapenemase genes. BD-CPO showed a sensitivity of 96.3% (155/161) for CPE detection; however, accurate Ambler class assignment was achieved in only 70.2% (113/161) of isolates. Misclassification occurred in 9.3% (15/161) of isolates, and six false-negative results (3.7%) were observed with the BD-CPO test, particularly among isolates harboring bla OXA genes. Both assays provide rapid detection of carbapenemase production compared to conventional phenotypic methods. However, NG-C5 demonstrated superior performance in carbapenemase gene identification and classification. Implementation of rapid carbapenemase detection assays can support timely therapeutic optimization and infection control interventions, although the results should be interpreted within a comprehensive diagnostic framework that includes molecular confirmation and full antimicrobial susceptibility testing. IMPORTANCE: Accurate detection of carbapenemase-producing Enterobacterales (CPE) is critical for guiding targeted antimicrobial therapy and implementing effective infection control strategies. Clinical microbiology laboratories rely on a variety of phenotypic and rapid diagnostic methods; however, their ability to correctly detect and classify carbapenemases remains variable. In this study, we compared the performance of the BD Phoenix CPO Detect and NG-Test CARBA 5 using whole-genome sequencing as the reference standard. Our results demonstrate important differences in diagnostic accuracy, particularly for OXA-type carbapenemases, providing practical evidence to guide laboratories in selecting reliable tools for rapid CPE detection and classification.
- 18 June 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (8) , e0089026
Open AccessEvaluation of BD Phoenix CPO Detect and NG-Test CARBA 5 for the detection and classification of carbapenemase-producing Enterobacterales using whole-genome sequencing as the reference standard
Rapid detection and accurate classification of carbapenemase-producing Enterobacterales (CPE) are essential for antimicrobial stewardship and infection prevention. We evaluated the performance of the BD Phoenix CPO Detect (BD-CPO) assay and the NG-Test CARBA 5 (NG-C5) using whole-genome sequencing (WGS) as the reference standard in a tertiary pediatric center. A total of 161 non-duplicate WGS-confirmed CPE isolates recovered from clinical and screening specimens were included. NG-C5 demonstrated a sensitivity of 99.4%, correctly identifying and classifying carbapenemase genes in 160 of 161 isolates, including those harboring dual carbapenemase genes. BD-CPO showed a sensitivity of 96.3% (155/161) for CPE detection; however, accurate Ambler class assignment was achieved in only 70.2% (113/161) of isolates. Misclassification occurred in 9.3% (15/161) of isolates, and six false-negative results (3.7%) were observed with the BD-CPO test, particularly among isolates harboring bla OXA genes. Both assays provide rapid detection of carbapenemase production compared to conventional phenotypic methods. However, NG-C5 demonstrated superior performance in carbapenemase gene identification and classification. Implementation of rapid carbapenemase detection assays can support timely therapeutic optimization and infection control interventions, although the results should be interpreted within a comprehensive diagnostic framework that includes molecular confirmation and full antimicrobial susceptibility testing. IMPORTANCE: Accurate detection of carbapenemase-producing Enterobacterales (CPE) is critical for guiding targeted antimicrobial therapy and implementing effective infection control strategies. Clinical microbiology laboratories rely on a variety of phenotypic and rapid diagnostic methods; however, their ability to correctly detect and classify carbapenemases remains variable. In this study, we compared the performance of the BD Phoenix CPO Detect and NG-Test CARBA 5 using whole-genome sequencing as the reference standard. Our results demonstrate important differences in diagnostic accuracy, particularly for OXA-type carbapenemases, providing practical evidence to guide laboratories in selecting reliable tools for rapid CPE detection and classification.
- Open Access
- 7 April 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (4) , e0367425
Achromobacter infections from a pediatric population in Qatar
- 7 April 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (4) , e0367425
Open AccessAchromobacter infections from a pediatric population in Qatar
- Open Access
- 20 February 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (2)
Persistence and spread of fluconazole-resistant Candida parapsilosis clinical isolates associated with increased ERG11 copies in Qatar
Candida parapsilosis is one of the most common species associated with candidemia infections globally. Recently, the emergence of fluconazole-resistant (FLU-R) C. parapsilosis has become a significant global public health concern. In this study, we investigated the genomic epidemiology and potential mechanisms of antifungal resistance among 51 hospital isolates in Qatar, of which 18 were FLU-R. Whole-genome SNP analysis revealed the presence of five major genetic clusters and evidence for cross-hospital transmission within clusters I, II and III. Cluster I had 21 isolates, including all 18 FLU-R isolates collected from 2015 to 2021. These 18 FLU-R isolates had no missense variants known to be associated with azole resistance in loci such as ERG11, ERG6 and TAC1 ; however, all FLU-R isolates had increased copy numbers of ERG11 , ranging from 3 to 7 copies. In addition, most FLU-R isolates ( n =16) had increased CDR1B copies (2–8 copies). These FLU-R isolates also had higher expression of ERG11 and CDR1B than sensitive strains. A genome-wide association study revealed 16 variants in several loci of unknown function that may be linked to resistance to FLU and 5-flucytosine. All cluster I isolates had unique missense mutations in EFG1 and UME6 that may play important roles in morphogenesis and biofilm formation. Our findings indicate these cluster I isolates may have evolved a greater propensity to persist within hospitals for prolonged periods and cause clonal transmission than isolates in other genetic clusters susceptible to fluconazole.
- 20 February 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (2)
Open AccessPersistence and spread of fluconazole-resistant Candida parapsilosis clinical isolates associated with increased ERG11 copies in Qatar
Candida parapsilosis is one of the most common species associated with candidemia infections globally. Recently, the emergence of fluconazole-resistant (FLU-R) C. parapsilosis has become a significant global public health concern. In this study, we investigated the genomic epidemiology and potential mechanisms of antifungal resistance among 51 hospital isolates in Qatar, of which 18 were FLU-R. Whole-genome SNP analysis revealed the presence of five major genetic clusters and evidence for cross-hospital transmission within clusters I, II and III. Cluster I had 21 isolates, including all 18 FLU-R isolates collected from 2015 to 2021. These 18 FLU-R isolates had no missense variants known to be associated with azole resistance in loci such as ERG11, ERG6 and TAC1 ; however, all FLU-R isolates had increased copy numbers of ERG11 , ranging from 3 to 7 copies. In addition, most FLU-R isolates ( n =16) had increased CDR1B copies (2–8 copies). These FLU-R isolates also had higher expression of ERG11 and CDR1B than sensitive strains. A genome-wide association study revealed 16 variants in several loci of unknown function that may be linked to resistance to FLU and 5-flucytosine. All cluster I isolates had unique missense mutations in EFG1 and UME6 that may play important roles in morphogenesis and biofilm formation. Our findings indicate these cluster I isolates may have evolved a greater propensity to persist within hospitals for prolonged periods and cause clonal transmission than isolates in other genetic clusters susceptible to fluconazole.
- Open Access
- 12 February 2026
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 15 (2) , e0110825
Draft genome sequence of a carbapenemase-producing Escherichia coli strain MB2513103 bearing OXA-1207 from Qatar
Multidrug-resistant Escherichia coli is considered an urgent public threat, causing sepsis and urinary tract infections. We report the draft genome of a carbapenemase-producing Escherichia coli strain, MB2513103, harboring a bla OXA-1207 gene isolated in Qatar. The genome statistics, along with the sequence type and resistance mechanisms, are predicted.
- 12 February 2026
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 15 (2) , e0110825
Open AccessDraft genome sequence of a carbapenemase-producing Escherichia coli strain MB2513103 bearing OXA-1207 from Qatar
Multidrug-resistant Escherichia coli is considered an urgent public threat, causing sepsis and urinary tract infections. We report the draft genome of a carbapenemase-producing Escherichia coli strain, MB2513103, harboring a bla OXA-1207 gene isolated in Qatar. The genome statistics, along with the sequence type and resistance mechanisms, are predicted.
- Open Access
- 3 February 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (2) , e0313525
Six-year retrospective comparison of GeneXpert MTB/RIF Ultra PCR and culture for pediatric tuberculosis diagnosis in non-sputum samples
Diagnosing tuberculosis (TB) in children is challenging due to the paucibacillary nature of the disease and difficulty in obtaining sputum samples. This 6-year retrospective study compared the diagnostic performance of the GeneXpert MTB/RIF Ultra PCR (GX-MTB/R-U) assay, an improved version of the MTB/RIF PCR (GX-MTB/R) assay, with conventional mycobacterial culture in pediatric non-sputum samples. A total of 417 non-sputum samples from a tertiary pediatric facility underwent simultaneous GX-MTB/R-U and culture testing. Performance was evaluated using conventional culture as a gold standard, and clinical review was used to resolve discordant results. GX-MTB/R-U demonstrated 93.9% sensitivity and 97.9% specificity when culture was used as the gold standard. Eight samples positive by GX-MTB/R-U assay but negative by culture were confirmed as true positive using clinical review of the patients, increasing the sensitivity to 95.1% and specificity to 100%. GX-MTB/R-U demonstrated excellent diagnostic performance in comparison to conventional culture and microscopy, particularly for paucibacillary and extrapulmonary samples. Our study results support the use of GX-MTB/R-U assay as a frontline diagnostic tool in pediatric TB, with culture reserved for confirmation of negative PCR results and antibiotic susceptibility testing. IMPORTANCE: Delays or inaccuracies in tuberculosis (TB) diagnosis can lead to treatment delays, disease progression, and poor clinical outcomes. This study provides compelling evidence on the excellent diagnostic performance of the GeneXpert MTB/RIF Ultra (GX-MTB/R-U) assay in pediatric non-sputum samples compared to conventional culture, the current gold standard. By demonstrating high sensitivity and specificity, particularly in extrapulmonary samples, the findings of our study highlight the potential of GX-MTB/R-U as a frontline TB diagnostic tool. The use of this assay in clinical practice could improve early detection, ensure timely initiation of antibiotic treatment, ultimately improving pediatric TB management and outcomes.
- 3 February 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (2) , e0313525
Open AccessSix-year retrospective comparison of GeneXpert MTB/RIF Ultra PCR and culture for pediatric tuberculosis diagnosis in non-sputum samples
Diagnosing tuberculosis (TB) in children is challenging due to the paucibacillary nature of the disease and difficulty in obtaining sputum samples. This 6-year retrospective study compared the diagnostic performance of the GeneXpert MTB/RIF Ultra PCR (GX-MTB/R-U) assay, an improved version of the MTB/RIF PCR (GX-MTB/R) assay, with conventional mycobacterial culture in pediatric non-sputum samples. A total of 417 non-sputum samples from a tertiary pediatric facility underwent simultaneous GX-MTB/R-U and culture testing. Performance was evaluated using conventional culture as a gold standard, and clinical review was used to resolve discordant results. GX-MTB/R-U demonstrated 93.9% sensitivity and 97.9% specificity when culture was used as the gold standard. Eight samples positive by GX-MTB/R-U assay but negative by culture were confirmed as true positive using clinical review of the patients, increasing the sensitivity to 95.1% and specificity to 100%. GX-MTB/R-U demonstrated excellent diagnostic performance in comparison to conventional culture and microscopy, particularly for paucibacillary and extrapulmonary samples. Our study results support the use of GX-MTB/R-U assay as a frontline diagnostic tool in pediatric TB, with culture reserved for confirmation of negative PCR results and antibiotic susceptibility testing. IMPORTANCE: Delays or inaccuracies in tuberculosis (TB) diagnosis can lead to treatment delays, disease progression, and poor clinical outcomes. This study provides compelling evidence on the excellent diagnostic performance of the GeneXpert MTB/RIF Ultra (GX-MTB/R-U) assay in pediatric non-sputum samples compared to conventional culture, the current gold standard. By demonstrating high sensitivity and specificity, particularly in extrapulmonary samples, the findings of our study highlight the potential of GX-MTB/R-U as a frontline TB diagnostic tool. The use of this assay in clinical practice could improve early detection, ensure timely initiation of antibiotic treatment, ultimately improving pediatric TB management and outcomes.